Fetal trimethadione syndrome
From Wikipedia, the free encyclopedia
Fetal trimethadione syndrome (also known as paramethadione syndrome, German syndrome, tridione syndrome, among others[1]) is a set of birth defects caused by the administration of the anticonvulsants trimethadione (also known as Tridione) or paramethadione to epileptic mothers during pregnancy.[2]
Fetal trimethadione syndrome is classified as a rare disease by the National Institute of Health's Office of Rare Diseases,[3] meaning it affects less than 200,000 individuals in the United States.[4]
The fetal loss rate while using trimethadione has been reported to be as high as 87%.[5]
[edit] Characteristics
Fetal trimethadione syndrome is characterized by the following major symptoms as a result of the teratogenic characteristics of trimethadione.[6][7]
- Cranial and facial abnormalities which include; microcephaly, midfacial flattening, V-shaped eyebrows, and a short nose
- Cardiovascular abnormalities
- Absent kidney and ureter
- Meningocele, a birth defect of the spine
- Omphalocele, a birth defect where portions of the abdominal contents project into the umbilical cord
- A delay in mental and physical development
[edit] References
- ^ Additional names include trimethadione embryopathy and trimethadione syndrome.
- ^ Multiple Congenital Anomaly/Mental Retardation (MCA/MR) Syndromes - Retrieved January 2007
- ^ Fetal trimethadione syndrome on the ORD website. Retrieved January 2007
- ^ Rare Diseases Retrieved January 2007
- ^ Teratology and Drug Use During Pregnancy Retrieved January 2007
- ^ Multiple Congenital Anomaly/Mental Retardation (MCA/MR) Syndromes - Retrieved January 2007
- ^ The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome Retrieved January 2007
[edit] External links
This audio file was created from a revision dated 2007-01-31, and does not reflect subsequent edits to the article. (Audio help)
